Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy: Study examines how definitions and thresholds of vaccine efficacy, coupled with different levels of implementation effectiveness and background epidemic severity, translate into outcomes. (Health Affairs, 2021)

Insurance coverage and financing landscape for HIV treatment and prevention in the USA (The Lancet, 2021)

Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States (JAMA, 2020)

Where is the ID in COVID-19? (Annals of Internal Medicine, 2020)

Medicare Part D and cost-sharing for antiretroviral therapy and preexposure prophylaxis (JAMA, 2020)

Clinical practices for measles-mumps-rubella vaccination among US pediatric international travelers (JAMA, 2020)

Comparative pricing of branded tenofovir alafenamide–emtricitabine relative to generic tenofovir disoproxil fumarate–emtricitabine for HIV preexposure prophylaxis: a cost-effectiveness analysis (Annals of Internal Medicine, 2020)

Assessment of job satisfaction and feeling valued in academic medicine (JAMA, 2019)

Do less harm: evaluating HIV programmatic alternatives in response to cutbacks in foreign aid (Annals of Internal Medicine, 2017)

The anticipated clinical and economic effects of 90–90–90 in South Africa (Annals of Internal Medicine, 2016)

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples (New England Journal of Medicine, 2013)

The impact of the President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and why it remains essential (Clinical Infectious Diseases, 2010)

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness (Clinical Infectious Diseases, 2009)

When to start antiretroviral therapy in resource-limited settings (Annals of Internal Medicine, 2009)

Gender differences in research grant applications and funding outcomes for medical school faculty (Journal of Women’s Health, 2009)

The survival benefits of AIDS treatment in the United States (The Journal of Infectious Diseases, 2006)

Expanded screening for HIV in the United States—an analysis of cost-effectiveness (New England Journal of Medicine, 2005)